These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1747220)

  • 1. Verapamil and nifedipine in combination for the treatment of hypertrophy heart disease.
    Kaesemeyer WH; Prisant LM; Carr AA
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):866-7. PubMed ID: 1747220
    [No Abstract]   [Full Text] [Related]  

  • 2. Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy.
    Ross EJ
    Am J Med; 1965 Dec; 39(6):994-1002. PubMed ID: 5853475
    [No Abstract]   [Full Text] [Related]  

  • 3. Verapamil and nifedipine in combination for the treatment of hypertension.
    Kaesemeyer WH; Carr AA; Bottini PB; Prisant LM
    J Clin Pharmacol; 1994 Jan; 34(1):48-51. PubMed ID: 8132851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic behavior of arterial pressure during exertion. Effects of treatment with 2 different calcium blockers: nifedipine and verapamil].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Gil de la Peña M
    Med Clin (Barc); 1988 Apr; 90(16):651-5. PubMed ID: 3294533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary hyperaldosteronism caused by unilateral macronodular hyperplasia].
    Bernardin M; Dorey F; Louvel A; Fouchard J; Chapuis Y; Luton JP
    Presse Med; 1989 Apr; 18(17):872-5. PubMed ID: 2525707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone versus nifedipine in essential hypertension.
    Henry M; Wehrlen M; Pelletier B; Capron MH
    Am J Cardiol; 1990 Jun; 65(23):36K-38K. PubMed ID: 2191588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on the pathogenesis of hypertension in primary hyperaldosteronism].
    Distler A; Just HJ; Philipp T
    Minerva Med; 1973 Aug; 64(58):3021-7. PubMed ID: 4742641
    [No Abstract]   [Full Text] [Related]  

  • 8. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of verapamil: comparative studies of verapamil with beta-blockers and nifedipine.
    Jackson SH
    Br J Clin Pract Suppl; 1988 Apr; 60():45-7. PubMed ID: 2908234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of and tolerance to combined therapy with dihydropyridine and non-dihydropyridine Ca antagonists in patients with moderate arterial hypertension].
    Iskenderov BG; Burmistrova LF; Vakina TN; Lokhina TV; Bogdanova SR
    Klin Med (Mosk); 2005; 83(7):37-40. PubMed ID: 16117423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
    Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
    J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of verapamil--hydrochlorothiazide-spironolactone therapy in hypertensive black patients.
    Hughes GS; Cowart TD; Conradi EC
    Clin Pharm; 1987 Apr; 6(4):322-6. PubMed ID: 3665385
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of enalapril and calcium antagonists on blood pressure and cerebral perfusion in elderly hypertensives.
    Traub YM; Ayache AS; Groshar D
    J Hypertens Suppl; 1991 Dec; 9(6):S378-9. PubMed ID: 1819000
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
    Ural E; Kozdag G; Kilic T; Ural D; Sahin T; Celebi O; Komsuoglu B
    J Hum Hypertens; 2008 Mar; 22(3):208-10. PubMed ID: 17928875
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
    Novo S; Riolo F; Pinto A; Davì G; Botindari C
    Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium channel blockers: verapamil and nifedipine.
    Foster BC
    Crit Care Update; 1983 Sep; 10(9):46-9. PubMed ID: 6555082
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone for all hypertensive patients?
    Rosendorff C
    J Hypertens; 2010 Jan; 28(1):13-4. PubMed ID: 20016304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arterial hypertension with secondary hyperaldosteronism, reversible by nifedipine, in systemic scleroderma].
    Gouet D; Rouffineau J; Marechaud R; Thomas P; Pourrat O; Alcalay M; Bontoux D
    Ann Med Interne (Paris); 1983; 134(8):736-8. PubMed ID: 6666913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effect of short-term treatment with nifedipine and verapamil on blood pressure, plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in patients with primary arterial hypertension I degree according to WHO].
    Widecka K; Marzecka J; Goździk J; Gruszczyńska M; Ciechanowski K; Czekalski S
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):228-30. PubMed ID: 7862584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.